Search Results

Background Mammography screening reduces breast cancer mortality by an estimated 26% to 41%. 1 , 2 However, false-positive recalls—recalling women with abnormal mammograms who, on further testing, are not found to have breast cancer—can cause

Background: To evaluate the quality of an organized mammography screening program based on the perception of screened women, we developed and validated the French-language Mammography Satisfaction Instrument (MSI). The study objective was to

Background: National health organizations offer contrasting guidelines for women aged 40–49 regarding when to begin and how often to use mammography screening for breast cancer. The ACS recommends average risk women aged 40–44 receive annual

mammography screening for women aged 50 to 74 years at average risk. 1 For women before age 50 years, the USPSTF recommendations state that screening is an individual decision, and women who place a higher value on potential benefit than potential harm may

D Byrne C . Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention . J Natl Cancer Inst 2001 ; 93 : 358 – 366 . 15 Gail M Rimer B . Risk of risk-based mammography screening, age 40

Aspegren K Janzon L . Mammographic screening and mortality from breast cancer: The Malmö mammographic screening trial . BMJ 1988 ; 297 : 943 – 948 . 21 Frisell J Eklund G Hellstrom L . Randomized study of mammography screening

increasingly available in the primary care setting for general screening populations. Figure 1 shows a decision tool for mammography screening from HealthDecision that illustrates a typical trajectory of 10,000 women aged ≥74 years who are screened for breast

, the net benefits are too small to recommend routine screening among younger women.” The evolving guidelines on mammography screening among younger women bring to the forefront a key issue in emerging health policy. The hallmark of comparative

for breast cancer in young, high-risk women with dense breast tissue. Sensitivity consistently less than 50% was observed in mammography screening trials. Furthermore, even in routinely screened high-risk patients, half of screen-detected breast

breast cancer screening recommendations following guideline changes: results of a national survey . JAMA Intern Med 2017 ; 177 : 877 – 878 . 15. Coldman A Phillips N Wilson C . Pan-Canadian study of mammography screening and mortality from